Weidong Liu Selected Research

Neoplasms (Cancer)

3/2024	Integrated profiling identifies ferredoxin 1 as an immune-related biomarker of malignant phenotype in glioma.
2/2024	Aptamers combined with immune checkpoints for cancer detection and targeted therapy: A review.
12/2023	The effects of doxorubicin loaded aptamer S3-linked DNA tetrahedrons on nasopharyngeal carcinoma.
5/2023	Chemical constituents, pharmacological effects, toxicology, processing and compatibility of Fuzi (lateral root of Aconitum carmichaelii Debx): A review.
6/2022	Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
6/2022	Circular RNA circ_0065378 upregulates tumor suppressor candidate 1 by competitively binding with miR-4701-5p to alleviate colorectal cancer progression.
1/2022	The Role of NR4A1 in the Pathophysiology of Osteosarcoma: A Comprehensive Bioinformatics Analysis of the Single-Cell RNA Sequencing Dataset.
1/2022	Multidimension Analysis of the Prognostic Value, Immune Regulatory Function, and ceRNA Network of LY6E in Individuals with Colorectal Cancer.
12/2021	The circular RNA circCRIM1 inhibits osteosarcoma progression through sponging miR-513.
11/2021	The possible role of SRMS in colorectal cancer by bioinformatics analysis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weidong Liu Research Topics

Disease

49	Neoplasms (Cancer) 03/2024 - 09/2004
10	Glioma (Gliomas) 03/2024 - 08/2011
9	Nasopharyngeal Carcinoma 12/2023 - 09/2005
9	Neoplasm Metastasis (Metastasis) 08/2023 - 04/2014
9	Infections 07/2023 - 09/2005
9	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2004
8	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 01/2017
7	Inflammation (Inflammations) 05/2023 - 01/2020
6	Colonic Neoplasms (Colon Cancer) 12/2019 - 01/2017
5	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 11/2018
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 05/2010
5	Lung Neoplasms (Lung Cancer) 01/2021 - 07/2013
5	Carcinogenesis 01/2018 - 09/2004
5	Nasopharyngitis 11/2014 - 09/2005
4	Obesity 10/2023 - 01/2017
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 09/2019
4	Insulin Resistance 01/2022 - 02/2018
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019 - 09/2013
3	Spinal Cord Injuries (Spinal Cord Injury) 05/2024 - 05/2018
3	Atherosclerosis 09/2023 - 02/2014
3	Leukemia 01/2023 - 09/2019
3	Ischemic Stroke 10/2022 - 01/2019
3	Fibrosis (Cirrhosis) 01/2022 - 09/2004
3	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2012
3	Stroke (Strokes) 01/2022 - 01/2019
3	Rheumatoid Arthritis 01/2022 - 01/2017
3	Hyperuricemia 01/2022 - 01/2022
3	Cerebral Infarction 12/2021 - 01/2019
3	Adenocarcinoma 01/2021 - 12/2018
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 04/2010
3	Dyslipidemias (Dyslipidemia) 01/2020 - 05/2019
3	Squamous Cell Carcinoma of Head and Neck 11/2019 - 11/2014
2	Ulcerative Colitis 05/2024 - 01/2023
2	Colitis 05/2024 - 09/2015
2	Atherosclerotic Plaque (Atheroma) 09/2023 - 01/2022
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2022 - 10/2002
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2021 - 01/2020
2	Cicatrix (Scar) 07/2021 - 05/2018
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2021 - 09/2019
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2019
2	Wounds and Injuries (Trauma) 12/2020 - 02/2017
2	Virus Diseases (Viral Diseases) 10/2020 - 06/2015
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 01/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 09/2019 - 04/2015
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 07/2014

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2013
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2012
8	CollagenIBA 05/2024 - 02/2014
7	Uric Acid (Urate)IBA 09/2023 - 01/2021
6	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
6	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2013
6	Messenger RNA (mRNA)IBA 01/2020 - 01/2007
4	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 09/2005
4	LipidsIBA 09/2023 - 07/2015
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 10/2016
4	Long Noncoding RNAIBA 01/2021 - 12/2019
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 02/2016
3	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 02/2018
3	flotillinsIBA 08/2023 - 07/2015
3	CytokinesIBA 03/2023 - 07/2020
3	6-methyladenineIBA 01/2023 - 01/2020
3	Circular RNAIBA 06/2022 - 12/2021
3	AntigensIBA 01/2022 - 01/2017
3	Phosphotransferases (Kinase)IBA 11/2021 - 09/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2018
3	CurcuminIBA 01/2018 - 01/2016
3	Vitamin K 2 (Vitamin K2)IBA 11/2009 - 05/2007
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2006 - 10/2002
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2006 - 10/2002
2	Dextran SulfateIBA 05/2024 - 09/2015
2	Hematoxylin (Haematoxylon)IBA 12/2023 - 09/2023
2	Eosine Yellowish-(YS) (Eosin)IBA 12/2023 - 09/2023
2	AntibodiesIBA 07/2023 - 04/2015
2	Therapeutic UsesIBA 05/2023 - 05/2018
2	N-methyladenosineIBA 01/2023 - 01/2021
2	Sincalide FDA Link 11/2022 - 06/2022
2	Transcription Factors (Transcription Factor)IBA 06/2022 - 01/2020
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2022 - 11/2021
2	Advanced Glycation End ProductsIBA 01/2022 - 01/2022
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2022
2	Insulin (Novolin)FDA Link 01/2022 - 02/2018
2	Indicators and Reagents (Reagents)IBA 11/2021 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2021 - 05/2018
2	trifolirhizinIBA 03/2021 - 05/2019
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 01/2019
2	p38 Mitogen-Activated Protein KinasesIBA 01/2020 - 09/2015
2	SaltsIBA 01/2020 - 05/2019
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 02/2018
2	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2020 - 01/2020
2	CholesterolIBA 01/2020 - 02/2014
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 12/2019 - 09/2015
2	Caspase 3 (Caspase-3)IBA 12/2019 - 04/2015
2	Butyric Acid (Butanoic Acid)IBA 01/2019 - 02/2017
2	WZ35 compoundIBA 01/2018 - 01/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018 - 06/2015

Therapy/Procedure

15	Therapeutics 02/2024 - 05/2010
5	Immunotherapy 02/2024 - 01/2020
5	Drug Therapy (Chemotherapy) 01/2021 - 02/2016
2	Aftercare (After-Treatment) 01/2023 - 08/2018